Articles producció científica> Medicina i Cirurgia

Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm

  • Dades identificatives

    Identificador: imarina:9216713
    Autors:
    Ferre-Vallverdu, MLigero, CVidal-Perez, RMartinez-Rubio, AVinolas, XAlegret, JM
    Resum:
    Background: The European Heart Rhythm Association (EHRA) score is a proven and validated tool for assessing the symptoms of atrial fibrillation (AF). Little is known about the variables related to this score and how it changes after cardioversion. Methods: We analyzed 744 patients undergoing elective cardioversion in whom AF-related symptoms were assessed at baseline and after 6 months of follow-up using the EHRA score. We assessed the association between the EHRA score and other clinical and echocardiographic variables at baseline and after 6 months of follow-up. Results: At 6 months of follow-up, we observed a reduction in the EHRA score in 50% and worsening in 2.8% of patients who remained in sinus rhythm (SR) compared with 34.6% and 11.3%, respectively, of patients with AF episodes (p<0.0001). Patients who maintained SR at 6 months were less symptomatic than those with AF (EHRA score 1.13 +/- 0.35 vs 1.42 +/- 0.59; p<0.0001). The independent predictors for reduction in the EHRA score after cardioversion were NYHA >= II at baseline and maintenance of SR (p<0.0001). Conclusion: The greatest improvement in AF-related symptoms was in patients who remained in SR at 6 months after cardioversion and in patients with worse NYHA functional class at baseline.
  • Altres:

    Autor segons l'article: Ferre-Vallverdu, M; Ligero, C; Vidal-Perez, R; Martinez-Rubio, A; Vinolas, X; Alegret, JM
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Alegret Colomé, Josep Maria / Ferré Vallverdú, Maria / Ligero Ferrer, Maria Carmen
    Paraules clau: Treatment response Symptoms improvement Symptom Spain Sinus rhythm Retrospective study Retrospective studies Registry Quality-of-life Propafenone Procedures Prediction Pathophysiology Outcomes Nyha functional class New york heart association class Middle aged Management Male Major clinical study Humans Human Follow up Flecainide Female European heart rhythm association score Electric countershock Ehra score Echocardiography Disease severity Disease exacerbation Disease association Dipeptidyl carboxypeptidase inhibitor Digoxin Controlled study Clinical practice Clinical feature Clinical assessment tool Cardioversion Cardiac patient Calcium channel blocking agent Beta adrenergic receptor blocking agent Atrial fibrillation Association Article Antiarrhythmic agent Angiotensin receptor antagonist Amiodarone Aged Adult
    Resum: Background: The European Heart Rhythm Association (EHRA) score is a proven and validated tool for assessing the symptoms of atrial fibrillation (AF). Little is known about the variables related to this score and how it changes after cardioversion. Methods: We analyzed 744 patients undergoing elective cardioversion in whom AF-related symptoms were assessed at baseline and after 6 months of follow-up using the EHRA score. We assessed the association between the EHRA score and other clinical and echocardiographic variables at baseline and after 6 months of follow-up. Results: At 6 months of follow-up, we observed a reduction in the EHRA score in 50% and worsening in 2.8% of patients who remained in sinus rhythm (SR) compared with 34.6% and 11.3%, respectively, of patients with AF episodes (p<0.0001). Patients who maintained SR at 6 months were less symptomatic than those with AF (EHRA score 1.13 +/- 0.35 vs 1.42 +/- 0.59; p<0.0001). The independent predictors for reduction in the EHRA score after cardioversion were NYHA >= II at baseline and maintenance of SR (p<0.0001). Conclusion: The greatest improvement in AF-related symptoms was in patients who remained in SR at 6 months after cardioversion and in patients with worse NYHA functional class at baseline.
    Àrees temàtiques: Saúde coletiva Planejamento urbano e regional / demografia Odontología Nutrição Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar Geriatrics and gerontology Geriatrics & gerontology General medicine Enfermagem Educação física Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciência de alimentos Biotecnología
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: maria.ferrev@urv.cat mariacarmen.ligero@urv.cat mariacarmen.ligero@urv.cat josepmaria.alegret@urv.cat
    Identificador de l'autor: 0000-0002-6117-5512
    Data d'alta del registre: 2024-07-27
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://www.dovepress.com/improvement-in-atrial-fibrillation-related-symptoms-after-cardioversio-peer-reviewed-fulltext-article-CIA
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Clinical Interventions In Aging. 16 739-745
    Referència de l'ítem segons les normes APA: Ferre-Vallverdu, M; Ligero, C; Vidal-Perez, R; Martinez-Rubio, A; Vinolas, X; Alegret, JM (2021). Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm. Clinical Interventions In Aging, 16(), 739-745. DOI: 10.2147/CIA.S305619
    DOI de l'article: 10.2147/CIA.S305619
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2021
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Geriatrics & Gerontology,Geriatrics and Gerontology,Medicine (Miscellaneous)
    Treatment response
    Symptoms improvement
    Symptom
    Spain
    Sinus rhythm
    Retrospective study
    Retrospective studies
    Registry
    Quality-of-life
    Propafenone
    Procedures
    Prediction
    Pathophysiology
    Outcomes
    Nyha functional class
    New york heart association class
    Middle aged
    Management
    Male
    Major clinical study
    Humans
    Human
    Follow up
    Flecainide
    Female
    European heart rhythm association score
    Electric countershock
    Ehra score
    Echocardiography
    Disease severity
    Disease exacerbation
    Disease association
    Dipeptidyl carboxypeptidase inhibitor
    Digoxin
    Controlled study
    Clinical practice
    Clinical feature
    Clinical assessment tool
    Cardioversion
    Cardiac patient
    Calcium channel blocking agent
    Beta adrenergic receptor blocking agent
    Atrial fibrillation
    Association
    Article
    Antiarrhythmic agent
    Angiotensin receptor antagonist
    Amiodarone
    Aged
    Adult
    Saúde coletiva
    Planejamento urbano e regional / demografia
    Odontología
    Nutrição
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    Geriatrics and gerontology
    Geriatrics & gerontology
    General medicine
    Enfermagem
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Ciências ambientais
    Ciência de alimentos
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar